Shell Asset Management Co. Sells 11,871 Shares of Encompass Health Corp (EHC)

Shell Asset Management Co. lessened its stake in Encompass Health Corp (AMEX:EHC) by 27.0% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 32,127 shares of the company’s stock after selling 11,871 shares during the period. Shell Asset Management Co.’s holdings in Encompass Health were worth $2,504,000 at the end of the most recent quarter.

Other institutional investors also recently added to or reduced their stakes in the company. Harvest Fund Management Co. Ltd purchased a new stake in Encompass Health in the 2nd quarter worth approximately $107,000. IFP Advisors Inc boosted its position in Encompass Health by 696.3% in the 3rd quarter. IFP Advisors Inc now owns 1,521 shares of the company’s stock worth $119,000 after purchasing an additional 1,330 shares in the last quarter. Bridgeworth LLC purchased a new stake in Encompass Health in the 2nd quarter worth approximately $127,000. Meeder Asset Management Inc. boosted its position in Encompass Health by 97.0% in the 2nd quarter. Meeder Asset Management Inc. now owns 2,092 shares of the company’s stock worth $142,000 after purchasing an additional 1,030 shares in the last quarter. Finally, Rehmann Capital Advisory Group boosted its position in Encompass Health by 108.3% in the 2nd quarter. Rehmann Capital Advisory Group now owns 2,233 shares of the company’s stock worth $151,000 after purchasing an additional 1,161 shares in the last quarter. Institutional investors and hedge funds own 93.18% of the company’s stock.

Encompass Health Corp has a 52 week low of $40.86 and a 52 week high of $59.29.

Encompass Health (AMEX:EHC) last announced its earnings results on Monday, October 29th. The company reported $0.91 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.79 by $0.12. The business had revenue of $1.07 billion for the quarter, compared to analyst estimates of $1.06 billion. The firm’s revenue for the quarter was up 8.8% on a year-over-year basis.

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, January 15th. Stockholders of record on Wednesday, January 2nd will be paid a dividend of $0.27 per share. This represents a $1.08 annualized dividend and a dividend yield of ∞. The ex-dividend date is Monday, December 31st.

EHC has been the topic of several recent research reports. Zacks Investment Research lowered Encompass Health from a “buy” rating to a “hold” rating in a research report on Wednesday, November 14th. UBS Group initiated coverage on Encompass Health in a research report on Thursday, November 15th. They issued a “buy” rating and a $86.00 price objective on the stock. Two research analysts have rated the stock with a hold rating and nine have issued a buy rating to the company’s stock. The stock currently has a consensus rating of “Buy” and an average target price of $72.09.

ILLEGAL ACTIVITY NOTICE: “Shell Asset Management Co. Sells 11,871 Shares of Encompass Health Corp (EHC)” was originally reported by Chaffey Breeze and is owned by of Chaffey Breeze. If you are accessing this article on another site, it was stolen and republished in violation of US and international trademark & copyright laws. The original version of this article can be read at https://www.chaffeybreeze.com/2018/12/01/shell-asset-management-co-sells-11871-shares-of-encompass-health-corp-ehc.html.

About Encompass Health

Encompass Health Corporation, formerly HealthSouth Corporation, is a provider of post-acute healthcare services, offering both facility-based and home-based post-acute services in 35 states and Puerto Rico through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies.

Featured Story: Dividend Stocks – Are They Right For You?

Institutional Ownership by Quarter for Encompass Health (AMEX:EHC)

Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply